New patent for Astrazeneca Ab drug BYDUREON PEN

Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from two suppliers. There are twenty…

The post New patent for Astrazeneca Ab drug BYDUREON PEN appeared first on DrugPatentWatch Blog.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: